Since its approval by the Food and Drug Administration, it has been increasingly prescribed as an effective treatment for weight loss in overweight and obese adults
Microvascular and Cardiovascular Outcomes According to Renal Function in Patients Treated With Once-Weekly Exenatide: Insights From the EXSCEL Trial
Long-term use: Clinical trials only ran 12 weeks, so long-term safety data (6+ months continuous use) comes from anecdotal reports
The retatrutide dosage chart shows an even more complex escalation schedule with a triple-receptor mechanism
These glycaemic effects can be maximised by undertaking activity during the postprandial period and engaging in activities for 45 min [101, 120]
In recent years, GLP-1 approvals have expanded beyond blood sugar management and weight loss to include other organs, like the heart, kidneys, and liver